+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comprehensive and efficient HBB mutation analysis for detection of beta-hemoglobinopathies in a pan-ethnic population

Comprehensive and efficient HBB mutation analysis for detection of beta-hemoglobinopathies in a pan-ethnic population

American Journal of Clinical Pathology 133(5): 700-707

Current methods that assay hemoglobin beta-globin chain variants can have limited clinical sensitivity when applied techniques identify only a predefined panel of mutations. Even sequence-based assays may be limited depending on which gene regions are investigated. We sought to develop a clinically practical yet inclusive molecular assay to identify beta-globin mutations in multicultural populations. We highlight the beta-globin mutation detection assay (beta-GMDA), an extensive gene sequencing assay. The polymerase chain reaction (PCR) primers are located to encompass virtually all hemoglobin beta locus (HBB) mutations. In addition, this assay is able to detect, by gap PCR, a common large deletion (Delta619 base pair), which would be missed by sequencing alone. We describe our 5-year experience with the beta-GMDA and indicate its capability for detecting homozygous, heterozygous, and compound heterozygous sequence changes, including previously unknown HBB variants. The beta-GMDA offers superior sensitivity and ease of use with comprehensive detection of HBB mutations that result in beta-globin chain variants.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052269949

Download citation: RISBibTeXText

PMID: 20395516


Related references

Molecular analysis of hemoglobinopathies in a large ethnic Hakka population in southern China. Medicine 97(45): E13034, 2018

Cross-Sectional Study for the Detection of Mutations in the Beta-Globin Gene Among Patients with Hemoglobinopathies in the Bengali Population. Genetic Testing and Molecular Biomarkers 21(1): 39-45, 2016

Large-scale population genetic analysis for hemoglobinopathies reveals different mutation spectra in central Greece compared to the rest of the country. American Journal of Hematology 82(7): 634-636, 2007

Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel. Genetics in Medicine 3(3): 168-176, May-June, 2001

Advantages of Reverse Dot Blot versus Amplification Refractory Mutation System in Beta-thalassemia mutation detection in the Iranian population. Journal of Medical Genetics 37(Supplement 1): S82, 2000

Comprehensive strategy for prenatal diagnosis of beta thalassemia by direct mutation detection using amplified dna. Pediatric Research 23(4 PART 2): 335A, 1988

Detection distribution and incidence of hemoglobinopathies and hemoglobin variants in a large multi ethnic state. American Journal of Human Genetics 49(4 SUPPL): 474, 1991

Hemoglobinopathies : community clues to mutation detection. Methods in Molecular Medicine 5: 169-183, 1996

Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia. Journal of Molecular Diagnostics 15(6): 745-753, 2014

Direct mutation analysis of beta-thalassemia genes in families of various ethnic origins residing in Germany. Blut 59(3): 237-239, 1989

DNA-polymorphic patterns linked to the beta-globin genes in German families affected with hemoglobinopathies and thalassemias: a comparison to other ethnic groups. Human Genetics 71(3): 219-222, 1985

Population genetics study of hemoglobinopathies in Uzbekistan. II. Population dynamics of hemoglobinopathies. Genetika 23(7): 1328-1333, 1987

Cumulative BRCA mutation analysis in the Greek population confirms that homogenous ethnic background facilitates genetic testing. Hereditary Cancer in Clinical Practice 13(1): 17, 2015

Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center. Cancer Genetics 220: 1-12, 2018

Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. European Urology 65(2): 367-369, 2014